Life Sciences

ATLANTA — Trammell Crow Co. (TCC) and Georgia Advanced Technology Ventures (GATV) — an affiliate of the Georgia Institute of Technology (Georgia Tech) — have completed construction of the first phase of Science Square, a mixed-use development situated adjacent to the Georgia Tech campus in Atlanta. Comprising 18 acres, the development features Science Square Labs, a life science building, and The Grace, a 14-story residential tower. Perkins + Will designed Science Square Labs, which totals 368,258 square feet and features lab and clean-up space. The 13-story building features a 38,000-square-foot solar panel array on top of the parking garage and 22 electric vehicle charging stations. Amenities at the property include a fitness center, conference space and private meeting rooms, and a tenant lounge and event space dubbed The Commons that features a 16,000-square-foot sky deck on the fifth floor. Portal Innovations has signed a 33,000-square-foot lease as the first tenant at the property, which includes 33,136 square feet of pre-built speculative lab and office suites, as well as space for custom-built units. The Grace, designed by Rule Joy Trammell + Rubio, comprises 280 units with a mix of market-rate and affordable residences. Amenities include a bike room, club room, outdoor …

FacebookTwitterLinkedinEmail

NEWARK, DEL. — Phase Sensitive Innovations, a provider of radio-frequency components, devices and systems, will open a 12,000-square-foot lab facility in Newark, about 15 miles southeast of Wilmington. The new space will complement the company’s existing 20,000-square-foot facility within Sandy Brae Industrial Park. The company plans to hire an additional 20 workers to staff the new facility by the end of the year and add 30 to 40 more jobs in subsequent years.

FacebookTwitterLinkedinEmail

COLUMBUS, OHIO — IRA Capital has acquired a 237,000-square-foot life sciences campus consisting of four buildings in the Easton submarket of Columbus. The purchase price was undisclosed. The property is near I-270, the John Glenn Columbus International Airport and across from Easton Town Center, the 1.7 million-square-foot retail destination. The buildings are mostly leased to biopharmaceutical company Sarepta Therapeutics and houses the company’s Gene Therapies Center of Excellence. Sarepta specializes in genetic medicines for rare diseases and has four FDA-approved drugs treating Duchenne Muscular Dystrophy. IRA closed the acquisition on an all-cash basis.

FacebookTwitterLinkedinEmail

BOSTON — General contractor Columbia Construction and locally based design firm Margulies Perruzzi Architects have completed a 20,000-square-foot office and life sciences project in Boston. The space serves as an innovation and workplace training center for biotechnology firm Boston Scientific Corp. and includes procedure rooms for simulated surgeries, conference rooms with movable walls, an auditorium and amenity spaces. R.W. Sullivan handled engineering services for the project.

FacebookTwitterLinkedinEmail
Manchester-by-the-Sea-Life-Sciences

MANCHESTER-BY-THE-SEA, MASS. — Massachusetts-based life sciences company Cell Signaling Technology has purchased a 50-acre site in Manchester-by-the-Sea, about 30 miles northeast of Boston, with plans to undertake a life sciences redevelopment. Designed by architecture firm HGA, the project will convert the site of an abandoned rock quarry into a research and innovation campus that will feature 250,000 square feet of space. Ten acres of the site are occupied by the Manchester Athletic Club. A construction timeline for the project, which will be developed in phases, is still being finalized.

FacebookTwitterLinkedinEmail
124-Westboro-Road-Grafton-Massachusetts

GRAFTON, MASS. — GFI Partners will undertake a 200,000-square-foot life sciences redevelopment project in Grafton, located in Worcester County. The Boston-based developer will convert a 33.2-acre site that was formerly part of the Grafton State Hospital campus into a two-building facility that can also support industrial usage under local zoning laws. MassDevelopment sold the parcel to GFI Partners for an undisclosed price. Construction is set to begin this summer and to be complete in early 2026.

FacebookTwitterLinkedinEmail

BOSTON — Basis Investment Group, a New York City-based commercial real estate debt and equity investment platform, has purchased an equity stake in Phase III of Innovation Square, a $416 million life sciences development in Boston’s Seaport District. The company purchased a minority stake of an undisclosed value from the developer, Related Beal, the Boston office of Related Cos. Located on a 1.8-acre site at 22 Drydock St., Phase III of Innovation Square will comprise a seven-story life sciences building totaling 340,000 square feet. Related Beal is leasing the site from the City of Boston for a 99-year term. The property’s life sciences space is fully preleased to Vertex Pharmaceuticals, a biopharmaceutical company based in Boston. The company also fully occupies Phase II of Innovation Square, a four-story life sciences building located at 6 Tide St. in Boston. In addition to laboratories and offices for Vertex, 22 Drydock will include dedicated lab space for Gloucester Marine Genomics Institute, a nonprofit that provides hands-on training for careers in labs to veterans and neighborhood high school students. Related Beal says the project is the first LEED Platinum and zero-net-carbon life sciences building in Boston. A net zero carbon building is a highly efficient …

FacebookTwitterLinkedinEmail

CAMBRIDGE, MASS. — Boston Properties (NYSE: BXP) has completed the previously announced sale of its 45 percent interest in a 577,000-square-foot life sciences development in Cambridge. The buyer was Norges Bank Investment Management. Construction is underway on the 16-story building, which is located at 290 Binney St. in the Kendall Square neighborhood and is fully preleased to AstraZeneca. Delivery is slated for spring 2026.

FacebookTwitterLinkedinEmail
Mesa-Labworks-San-Diego-CA

SAN DIEGO — King Street Properties has released plans to redevelop a creative office building at 5825 Oberlin Drive in San Diego into a Mesa Labworks, a speculative lab and life sciences facility. Construction of Mesa Labworks’ first two spec lab suites is currently underway. Located in the Sorrento Mesa submarket, the 60,000-square-foot building will offer move-in ready spec lab solutions, with suites ranging from 8,000 square feet to 15,000 square feet. Scheduled for completion in August 2024, the new suites will deliver state-of-the-art lab infrastructure. Mike Novkov, Bill Cavanagh and Brett Ward of Cushman & Wakefield are handling leasing for the project.

FacebookTwitterLinkedinEmail

WOBURN, MASS. — Type One Energy Group has signed a 15,500-square-foot life sciences lease in the northern Boston suburb of Woburn. The Wisconsin-based provider of clean energy solutions is relocating from nearby Somerville to 299 Washington St., which is owned by Cummings Properties. The new space will house office, manufacturing and lab uses. Al Diamond internally negotiated the lease on behalf of Cummings Properties. No third-party brokers were involved in the deal.

FacebookTwitterLinkedinEmail
Newer Posts